C14ORF167 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.014200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.314200E-01
Normal-vs-Stage2
7.617400E-01
Normal-vs-Stage3
1.705860E-02
Normal-vs-Stage4
5.884000E-01
Stage1-vs-Stage2
4.644100E-02
Stage1-vs-Stage3
2.329600E-02
Stage1-vs-Stage4
8.810600E-01
Stage2-vs-Stage3
7.573500E-04
Stage2-vs-Stage4
4.634000E-01
Stage3-vs-Stage4
2.146800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.549600E-01
Normal-vs-AfricanAmerican
7.752000E-02
Normal-vs-Asian
3.688800E-01
Caucasian-vs-AfricanAmerican
1.010390E-01
Caucasian-vs-Asian
2.551000E-01
AfricanAmerican-vs-Asian
3.059800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.750000E-01
Normal-vs-Female
9.220200E-01
Male-vs-Female
8.835600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.637200E-01
Normal-vs-Age(41-60Yrs)
8.680600E-01
Normal-vs-Age(61-80Yrs)
7.554600E-01
Normal-vs-Age(81-100Yrs)
8.490000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.391400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.183200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.958400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.470000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.265000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.545600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.866600E-01
Normal-vs-Daily Drinker
9.502600E-01
Normal-vs-Weekly Drinker
6.255000E-01
Normal-vs-Occasional Drinker
5.722600E-01
Normal-vs-Social Drinker
8.757400E-01
Non Drinker-vs-Daily Drinker
5.947400E-01
Non Drinker-vs-Weekly Drinker
7.508600E-01
Non Drinker-vs-Occasional Drinker
4.415800E-02
Non Drinker-vs-Social Drinker
4.204000E-01
Daily Drinker-vs-Weekly Drinker
5.315600E-01
Daily Drinker-vs-Occasional Drinker
2.375800E-01
Daily Drinker-vs-Social Drinker
6.795800E-01
Weekly Drinker-vs-Occasional Drinker
8.627700E-02
Weekly Drinker-vs-Social Drinker
3.658400E-01
Occasional Drinker-vs-Social Drinker
5.532600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.847570E-01
Normal-vs-Grade 2
3.346500E-02
Normal-vs-Grade 3
1.807930E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.402000E-01
Grade 1-vs-Grade 3
6.010200E-01
Grade 1-vs-Grade 4
1.847570E-01
Grade 2-vs-Grade 3
3.828000E-01
Grade 2-vs-Grade 4
3.346500E-02
Grade 3-vs-Grade 4
1.807930E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.486800E-01
Normal-vs-NonDiabetic
8.706800E-01
Diabetic-vs-NonDiabetic
7.396000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.728760E-01
Normal-vs-NoPancreatitis
8.619800E-01
Pancreatitis-vs-NoPancreatitis
1.007200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.924800E-01
Normal-vs-N1
8.435000E-01
N0-vs-N1
6.498600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.647800E-01
Normal-vs-TP53-NonMutant
7.546200E-01
TP53-Mutant-vs-TP53-NonMutant
7.904200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
